{Reference Type}: Editorial
{Title}: Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial.
{Author}: Sano D;Oridate N;
{Journal}: Transl Cancer Res
{Volume}: 12
{Issue}: 5
{Year}: 2023 May 31
{Factor}: 0.496
{DOI}: 10.21037/tcr-23-48